Go Pro

Dudley & Shanley Inc. Has $14.10 Million Position in Danaher Corporation $DHR

Danaher logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Dudley & Shanley reduced its Danaher stake by 35.6% in the second quarter, selling 40,857 shares and retaining 74,024 shares valued at approximately $14.1 million. Institutional investors collectively own 79.05% of Danaher.
  • Danaher exceeded quarterly expectations, reporting $1.94 in adjusted earnings per share on $6.26 billion in revenue, with revenue increasing 5.5% year over year.
  • Analysts maintain a generally positive outlook, with a “Moderate Buy” consensus and an average price target of $228.91, despite several firms recently lowering their targets.
  • Five stocks to consider instead of Danaher.

Dudley & Shanley Inc. decreased its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 35.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 74,024 shares of the conglomerate's stock after selling 40,857 shares during the period. Danaher makes up 2.1% of Dudley & Shanley Inc.'s holdings, making the stock its 23rd biggest position. Dudley & Shanley Inc.'s holdings in Danaher were worth $14,100,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of DHR. Sivia Capital Partners LLC increased its holdings in shares of Danaher by 6.3% during the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate's stock worth $397,000 after purchasing an additional 119 shares during the period. First Trust Advisors LP boosted its stake in shares of Danaher by 34.5% in the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate's stock valued at $10,947,000 after buying an additional 14,217 shares during the period. Main Street Financial Solutions LLC boosted its stake in shares of Danaher by 40.2% in the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate's stock valued at $610,000 after buying an additional 886 shares during the period. Ieq Capital LLC grew its position in Danaher by 64.2% during the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate's stock worth $14,957,000 after buying an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC grew its position in Danaher by 30.7% during the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate's stock worth $273,000 after buying an additional 325 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Stock Performance

Danaher stock opened at $204.34 on Monday. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The business's 50-day moving average price is $190.67 and its two-hundred day moving average price is $194.02. The stock has a market cap of $143.65 billion, a PE ratio of 36.30, a P/E/G ratio of 2.55 and a beta of 0.78.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion during the quarter, compared to analysts' expectations of $6.12 billion. During the same quarter in the prior year, the business earned $0.77 earnings per share. The business's revenue for the quarter was up 5.5% compared to the same quarter last year. As a group, analysts expect that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. UBS Group dropped their price objective on Danaher from $270.00 to $250.00 and set a "buy" rating for the company in a report on Wednesday, April 22nd. The Goldman Sachs Group decreased their price target on Danaher from $265.00 to $230.00 and set a "buy" rating on the stock in a research report on Monday, April 13th. Rothschild & Co Redburn set a $205.00 price target on Danaher in a research note on Friday, April 17th. HSBC cut their price objective on shares of Danaher from $270.00 to $230.00 and set a "buy" rating for the company in a research report on Wednesday, June 3rd. Finally, JPMorgan Chase & Co. decreased their target price on shares of Danaher from $275.00 to $245.00 and set an "overweight" rating on the stock in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Danaher currently has an average rating of "Moderate Buy" and an average target price of $228.91.

Get Our Latest Research Report on Danaher

Danaher Company Profile

(Free Report)

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines